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Monocyte-derived macrophages are essential for
recovery after spinal cord injury, but their homing
mechanism is poorly understood. Here, we show
that although of common origin, the homing of proin-
flammatory (M1) and the ‘‘alternatively activated’’
anti-inflammatory (M2) macrophages to traumatized
spinal cord (SC) was distinctly regulated, neither
being through breached blood-brain barrier. The
M1 macrophages (Ly6chiCX3CR1lo) derived from
monocytes homed in a CCL2 chemokine-dependent
manner through the adjacent SC leptomeninges.
The resolving M2 macrophages (Ly6cloCX3CR1hi)
derived from monocytes trafficked through a remote
blood-cerebrospinal-fluid (CSF) barrier, the brain-
ventricular choroid plexus (CP), via VCAM-1-VLA-4
adhesion molecules and epithelial CD73 enzyme for
extravasation and epithelial transmigration. Block-
age of these determinants, or mechanical CSF flow
obstruction, inhibited M2 macrophage recruitment
and impaired motor-function recovery. The CP,
along with the CSF and the central canal, provided
an anti-inflammatory supporting milieu, potentially
priming the trafficking monocytes. Overall, our
finding demonstrates that the route of monocyte
entry to central nervous system provides an instruc-
tional environment to shape their function.
INTRODUCTION
Infiltration of circulating monocytes after mechanical injury to the
central nervous system (CNS) has been generally assumed to
reflect mechanical damage to the parenchymal blood-brain
barrier (BBB). Nevertheless, at early stages after mechanicalinjury, there is no direct evidence for escape of cellular elements
across the breached BBB, whose disruption is assessed by dye
or protein leakage; rather, several studies have shown paren-
chymal infiltration of monocytes at the subacute phase when
the BBB is resealed. In addition, blood-derived macrophages
contribute to CNS repair, in part by displaying resolving M2
phenotype (Kigerl et al., 2009; Rapalino et al., 1998; Shechter
et al., 2009; Yin et al., 2006). Thus, the posttraumatic CNS entry,
of at least some macrophages, seems to represent controlled
recruitment needed for repair.
Outside the CNS, the phenotype of macrophages, derived
from circulating monocytes homing to injured tissues (hereafter
abbreviated as monocyte-macrophages), reflects two phases.
The initial phase is characterized by Ly6chiCX3CR1lo mono-
cyte-macrophages, corresponding to the ‘‘classically activated’’
(M1) cells, which have been shown to possess proinflammatory,
phagocytic, and proteolytic functions, essential for damaged
tissue digestion and debris removal. The second phase is asso-
ciated with Ly6cloCX3CR1hi monocyte-macrophages, ‘‘alterna-
tively activated’’ (M2)macrophages, which are anti-inflammatory
in nature and are involved in tissue regeneration, growth, angio-
genesis, and matrix deposition, thereby supporting tissue
remodeling (Arnold et al., 2007; Nahrendorf et al., 2007). It is still
unclear whether the distinct macrophage populations are an
outcome of monocyte recruitment in two waves (Nahrendorf
et al., 2007) or in situ phenotypic conversion of the already
recruited cells (Arnold et al., 2007).
In the context of the CNS, which is separated from the circu-
lation by a system of barriers, a fundamental question is how
such cells gain access to the injured CNS parenchyma. Here,
we studied the recruitment of monocyte-macrophages to spinal
cord (SC) parenchyma after mechanical injury. Two monocyte-
macrophage populations were found in the traumatized SC,
corresponding to the M1 and M2 classes. The M1 monocyte-
macrophages were found to derive frommonocytes that entered
the traumatized SC via CCL2 through the adjacent SC leptome-
ninges, whereas the M2 cells came from monocytes that
trafficked through the brain-ventricular choroid plexus (CP), viaImmunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc. 555
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entry route is an M2-supporting milieu.
RESULTS
Two Distinct Populations of Monocyte-Macrophages
Are Actively Recruited to the Injured SC Parenchyma
To follow the route ofmonocyte entry into theSCafter trauma,we
employed the contusive model of spinal cord injury (SCI), of
moderate severity, which resulted in an average motor recovery
of 4.4 ± 0.3 (n = 38) according to Basso Motor Score (BMS)
(Basso et al., 2006). To specifically follow the infiltrating
monocyte-derived cells, distinct from CNS-resident microglia,
we used bone marrow (BM) chimeric mice, in which head-pro-
tected irradiated C57BL/6J recipients were reconstituted with
labeled Cx3cr1GFP/+ BM cells (henceforth termed Cx3cr1GFP/+
chimeras). Head-shielded chimeras, in the absence of SCI,
exhibit no noticeablemonocyte entry to the brain or SC (Shechter
et al., 2009). Moreover, irradiation of SC does not affect mono-
cyte recruitment (Ajami et al., 2007). Nevertheless, because it
has been argued that the BM chimeric model (though without
shielding) is confounded by some unavoidable artifacts (Ajami
et al., 2007; Mildner et al., 2007), we confirmed our findings by
experimental models that involved neither irradiation nor hema-
topoietic stem cell transplantation.
Cx3cr1GFP/+ chimeras were subjected to SCI, and the excised
SCs were analyzed by flow cytometry. Monocyte-macrophages
could barely be detected in the lesion site at the first day postin-
jury (day 0), a time when the BBB is most severely breached
(demonstrated by dye extravasation) (Noble and Wrathall,
1989), though hemorrhage occurred (measured by erythrocyte
presence) (Figure 1A). The monocyte-macrophages expressed
the macrophage and microglial differentiation marker Iba-1 (Fig-
ure 1B) and were previously found by us to express other macro-
phage markers, including Mac-3 and F4/80 (Shechter et al.,
2009). Quantitative analysis revealed accumulation of two dis-
tinct subsets with different kinetics, first Ly6chiCx3cr1-GFPlo
monocyte-macrophages, and subsequently Ly6cloCx3cr1-
GFPhi monocyte-macrophages (Figure 1B). At day 7, the
Ly6cloCx3cr1-GFPhi monocyte-macrophages expressed char-
acteristic M2 surface markers (Dectin1, interleukin-4 receptor
a chain [IL-4Ra], CD206-Mannose receptor) and anti-inflamma-
tory cytokines (IL-10 and TGF-b), whereas the Ly6chiCx3cr1-
GFPlo monocyte-macrophages expressed the proinflammatory
cytokines IL-1b and tumor necrosis factor-a (TNF-a) (Figure 1C).
Quantitative real-time PCR (qRT-PCR) of the two populations
separately sorted from injured (day 5) parenchyma confirmed
that the Ly6cloCx3cr1-GFPhi and the Ly6chiCx3cr1-GFPlo
subsets displayed M2 and M1 characteristics, respectively
(Figure 1D).
Next, we tested the effect of pertussis toxin (Ptx), an inhibitor
of Gai-mediated chemokine-receptor signaling, on monocyte-
macrophages homing to the injured SC. Injured CD45.1+ mice
were intravenously injected 1 day after injury with CD115+
monocytes (isolated from Cx3cr1GFP/+CD45.2 animals) either
Ptx treated or untreated (3 3 106 cells per recipient) (Shechter
et al., 2009). Flow cytometric analysis of recipient mouse
tissues 2 days after transfer showed that whereas untreated
monocytes homed to the injured SC, the Ptx pretreatment556 Immunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc.almost completely prevented monocyte accumulation in the
injured SC, without diminishing their numbers in the blood (Fig-
ure 1E). Thus monocyte entry into the injured SC parenchyma
relies on an active mechanism.
Considering the parenchymal blood-spinal cord barrier vascu-
lature (the spinal analogy to the BBB vasculature) as a possible
site for active monocyte entry, SCs of injured Cx3cr1GFP/+
chimeras were excised after transcardial perfusion and were
analyzed by immunohistochemistry. Monocytes were barely
detected in association with parenchymal blood vessels within
the lesion site or its surroundings (Figure 1F). We also did not
observe during the first 14 days ‘‘perivascular cuffs,’’ a micro-
scopically identifiable structure in which leukocytes accumulate
between the basement membranes of the parenchymal vascula-
ture, a typical feature of BBB transmigration (Takigawa et al.,
2010). Though we cannot exclude infrequent events of BBB
crossing, the above led us to search for alternative site(s) and
pathway(s) for monocyte entry. The leptomeninges and the CP,
recently identified as CNS entry sites for leukocytes (Bartholo-
ma¨us et al., 2009; Reboldi et al., 2009), were therefore examined.
The SC Leptomeninges Facilitate Homing to the Lesion
Site of M1 Monocyte-Macrophages
Considering its anatomical proximity to the lesion site, we tested
the SC leptomeninges. A reduced immunostaining for the tight
junction molecule occludin expressed by endothelial cells was
seen in whole-mount SC leptomeninges, isolated at day 1 post-
injury, thus revealing fenestration in endothelial sealing (Fig-
ure 2A). Immunohistochemical analyses as well as quantitative
flow cytometry of SC leptomeninges dissected from injured
Cx3cr1GFP/+ chimeras revealed the postinjury homing of GFP+
monocytes to the leptomeninges adjacent to the injury site
(Figures 2B–2D). This was verified in nonchimeric models by
intravenously injecting injured mice with either GFP+CD115+
monocytes (the day of injury) or PE-conjugated CD11b anti-
bodies (1 day before injury) (Figure S1 available online).
The meningeal homing monocytes were primarily of the
Ly6chiCx3cr1-GFPlo phenotype (Figure S1). No significant post-
trauma recruitment was observed in SC leptomeninges distal to
the site, cerebral meninges, or parenchyma of the distal SC or
the brain (Figure S1).
The chemokine CCL2 (MCP-1) is known to facilitate recruit-
ment of Ly6chi monocytes, which are CCR2+, to lesion sites
outside and within the CNS (Mildner et al., 2007), so we tested
whether CCL2 blocking affected monocyte homing through the
leptomeninges. Cx3cr1GFP/+ chimeras were intraperitoneally in-
jected with CCL2 blocking antibodies (2H5) or with IgG isotype
controls on the day of SC contusion. The SC leptomeninges
were analyzed by flow cytometry 1 day later (peak monocyte
homing; Figure 2D). CCL2 antibody treatment significantly
reduced monocyte homing of Ly6chiCx3cr1-GFPlo type to the
leptomeninges with no effect on blood populations (Figure 2E).
We repeated the experiment by administering the antibodies
on the day of injury and 48 hr later and analyzed the injured SC
on day 5, when the two monocyte-macrophage subtypes
were detectable. CCL2 antibodies caused a significant reduc-
tion, specifically in the M1 (Ly6chiCx3cr1-GFPlo) monocyte-
macrophages, with no effect on the appearance of M2
(Ly6cloCx3cr1-GFPhi) monocyte-macrophages at the lesion site
Figure 1. M1 and M2 Monocyte-Macro-
phages Are Actively Recruited to Injured
SC Parenchyma
(A–C) Flow cytometry analysis of lesion sites of
injured Cx3cr1GFP/+ chimeras.
(A) Erythrocytes and GFP+ monocyte-macro-
phages (n = 3–5 mice).
(B) M1 and M2 monocyte-macrophage pop-
ulations (based on GFP and Ly6c). (i) Histogram for
Iba-1. (ii) Quantitative kinetic analysis. ANOVA:
F13,27 = 19.5, *p = 0.0001 relative to uninjured.
(C) Pooled (n = 10–20) lesion sites (d7) analyzed for
M1 and M2 markers and intracellular cytokines.
(D) Monocyte-macrophage populations were
separately sorted by flow cytometry from the lesion
parenchyma (d5; n = 20 chimeras) and analyzed by
qRT-PCR. The same experimental results were
used, but each graph is presented relative to
the expression of the reciprocal subset, defined
as 100.
(E) Analysis of CD45.1 injured mice, 3 days after
SCI and 2 days after i.v. injection of monocytes (i.v.
at d1; Cx3cr1GFP/+; with or without pertussis toxin
[ptx] pretreatment). Student’s t test, n = 3 pools
(of 2 mice) in each group: blood p = 0.197, SC
p = 0.0001. Cells were Ly6c pregated.
(F) Cx3cr1GFP/+ chimeras SC stained for GFP and
CD31. n = 4 mice per time point, three depths.
Data are represented as mean ± SEM. Scale bars
represent 50 mm.
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Figure 2. CCL2-Dependent Homing of M1 Monocyte-Macrophages
to the Injured SC via the Leptomeninges
(A) SC leptomeninges stained for occludin and CD31. Arrowheads indicate
vessels lacking tight junctions. n = 4 mice.
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558 Immunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc.(Figure 2F). To strengthen the relationship between the mono-
cyte-macrophages found in the injured parenchyma and their
entry gate, in an independent experiment we concurrently tested
the lesion site along with the two potential gates at day 5;
whereas the injured parenchyma and the covering leptome-
ninges showed reduced monocytic infiltration, specifically of
the Ly6chiCx3cr1-GFPlo subset, the choroid plexus showed no
change (Figure S1).
Healing M2 Monocyte-Macrophages in the Injured
Spinal Cord Are Recruited through the Choroid Plexus
The above results led us to consider a distinct route for M2
monocyte-macrophage recruitment; we focused on the brain
ventricular CP, despite its anatomical distance. Examination of
brain sections stained with cresyl violet revealed irregular CP
morphology at day 1 after injury (Figure 3A), a sign for blood-
cerebrospinal fluid barrier (BCSFB) breaching. Immunostaining
for tight junction molecules (Zo-1 and occludin) of the CP
dissected several hours or 1 day after SCI revealed patches of
disrupted epithelial tight junction organization (Figures 3B and
3C), which was not seen in CP dissected from uninjured mice.
Intact vessels were seen in such patches (Figure 3B), ruling out
mechanical perturbation during tissue isolation. qRT-PCR of
dissected CP confirmed reduced expression after injury of
Ocln, encoding Occludin (Figure 3C).
Evaluating the CP of SC-injured Cx3cr1GFP/+ chimeras
revealed injury-induced homing of GFP+ monocytes (Figures
3D–3G). Although basal amount of monocytes were found in
the CP of uninjured animals, a burst of freshly recruited GFP+
monocytes to the CP was seen within the first hours posttrauma
(Figure 3G). Thereafter, the amount returned close to the basal
surveillance quantities. However, some degree of subsequent
influx through the CP probably continued. Circulating myeloid
homing to the CP after SCI was verified in nonchimeric models
by intravenous injection either of CD115+ monocytes (GFP+ or
DIR labeled; 4 hr after contusion) or of PE-conjugated CD11b
antibody (1 day before injury) to spinally injured mice (Figure S2).
The monocytes seen at the CP of Cx3cr1GFP/+ chimeras were
mainly of the Ly6cloCx3cr1-GFPhi type (Figure S2). These cells
included both CP-surveying monocytes and the M2-commited
or precursor cells en route to the site, which were indistin-
guishable based on these markers. CP-Ly6cloCx3cr1-GFPhi
cells expressed the M2 markers Dectin-1, IL-4Ra, and CD206(B) GFP+ cells in the leptomeninges of SC sections of injured Cx3cr1GFP/+
chimeras. n = 4 mice.
(C) Whole-mount staining of SC leptomeninges dissected out from
Cx3cr1GFP/+ chimeras. n = 4 mice per time point.
(D) Quantification by flow-cytometric analysis of GFP+ cells in dissected SC
leptomeninges lining the injured site. Values are absolute cell numbers per
10,000 live cells. ANOVA: F6,14 = 4.26, *p = 0.011 relative to uninjured.
(E and F) Spinally injured Cx3cr1GFP/+ chimeras, intraperitoneally injected
with CCL2 (or isotype-matched IgG) antibodies, analyzed on d1 for SC lep-
tomeninges (E) or at d5 for lesion sites (F). CCL2 inhibition reduced
Ly6chiCx3cr1-GFPlo trafficking. Two-way ANOVA: (E) n = 5–6 mice; F1,17 = 8.2,
p = 0.01; (F) n = 4–7 mice; F1,17 = 8.8, p = 0.008. Values are absolute cell
numbers in 0.5 cm SC tissue. As a control, blood was analyzed by two-way
ANOVA: (E) F1,16 = 0, p = 0.96; (F) F1,20 = 1.8, p = 0.2.
Data are represented as mean ± SEM. Scale bars represent 100 mm in (A) and
(C) and 10 mm in (B). See also Figure S1.
Figure 3. SCI Leads to Brain Choroid Plexus Activation and Monocyte Recruitment
(A–C) Morphological changes at the CP after SCI.
(legend continued on next page)
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CP myeloid population or their progenitors (Anandasabapathy
et al., 2011), expressed themonocyticmarker CD115 and lacked
the macrophage differentiation marker Mac-3 and the microglial
and macrophage (including resident CP macrophage [Chinnery
et al., 2010]) marker Iba-1 (Figures 3H and 3I).
qRT-PCR of excised CP for measurement of expression of
adhesion molecules and chemokine genes revealed dynamic
and selective changes in response to SCI (Figure 3J). Cx3cl1
(Fractalkine), Vcam1, and Nt5e (encoding CD73) showed a
transient elevation during the first day after injury. Notably, the
CP of uninjured Cx3cr1GFP/+ chimeras and wild-type mice
showed no differences in the expression of these key immune-
guiding molecules (Figure S2). Simultaneous multiplex analysis
for various myeloid-specific chemoattractants revealed that
macrophage colony-stimulating factor (M-CSF), the ligand of
CD115, was the predominant factor expressed in the CP and
the one that showed the highest elevation after injury (Figures
3K and S2). These changes were specific to the CP; the excised
SC exhibited its own distinct pattern of chemokine changes
(Figure S2).
We focused on the enzyme CD73 and the integrin ligand
VCAM-1 as potential homing determinants for monocytes cross-
ing through the CP. Immunohistochemical analysis confirmed
the selective expression of these two molecules in the CP after
SCI during the first few days after the injury (Figure S3). High
and uniform expression of CD73 was noted in choroidal epithe-
lium (Figure 4A), but not in the CP vasculature and not in paren-
chymal or leptomeningeal vessels of either the brain or the SC at
all tested time points (Figure S3). Increased reactivity of CD73 in
theCP epitheliumwas noted in the first few days (d0–d2) after the
injury, in line with gene expression data (Nt5e) (Figure 3J). CD73
was previously shown to be exclusively expressed within the
mouse CNS in the cuboidal epithelial lining of the CP (and not
in CNS endothelium), facilitating epithelial transmigration during
experimental autoimmune encephalomyelitis (EAE) (Mills et al.,
2008). CD73 is also expressed by leukocytes (Mills et al., 2008)
but not monocytes (Thomson et al., 1990). We verified that circu-
lating monocytes were devoid of CD73 after SCI (Figure 4B), in
line with reported results after ischemic injury (Bo¨nner et al.,
2012).
To block CD73-dependent trafficking, we systemically
injected (for 14 days) a,b methylene-ADP (APCP), a pharmaco-
logical CD73 inhibitor (Synnestvedt et al., 2002). A significant
reduction in monocyte-macrophages at the lesion site of
CD45.1/CD45.2 BM chimeric mice was observed (Figure 4C).(A) Cresyl violet staining; arrowheads indicate epithelial swelling, pointer indicates
material. n = 3–4 animals.
(B and C) Staining of CP for tight junctions (Zo-1 in B and occludin in C) and CD
animals per time point; qualitatively similar. (Cii) qRT-PCR analysis of isolated CP
(D–I) GFP+ cells in the CP of SC-injured Cx3cr1GFP/+ chimeras.
(D–F) GFP+ cells in CP sections (D) or whole mounts (E and higher magnification
(G–I) Flow cytometry analysis.
(G) Quantitative kinetics. Values are absolute cell numbers per 10,000 live cells. AN
(H) Dot plot of CP (d0; chimera) for Iba-1 and GFP.
(I) Marker expression; slash indicates heterogeneity; isotype controls served as n
(J and K) CPs analyzed by (J) qRT-PCR (n = 3–4 per time point; ANOVA; *relative to
fold of change relative to noninjured; ANOVA; F6,9 = 4.96, p = 0.018).
Data are represented as mean ± SEM. Scale bars represent 100 mm in (D) and (E
560 Immunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc.This effect was reproduced in Cd73/ mice; cell recruitment
was traced either by in situ labeling of the cells with CFSE
24 hr before the injury (Figure 4D) or by monitoring
CD45hiCD11bhi populations at the lesion site (Figure S3; Sedg-
wick et al., 1991). No reduction of blood-circulating monocytes
was detected in APCP-treated mice or in Cd73/ mice (Figures
4C and 4D).
We next examined VCAM-1 involvement in trafficking.
VCAM-1 was induced in CP capillaries during the first few
days after the insult (Figures 4E and S3) but not on parenchymal
vessels at the lesion site nor on the leptomeninges vessels of
the SC (at the lesion site or distally) or the brain (Figure S3),
as previously reported (Kalderon, 2005; Schnell et al., 1999).
From day 7 onward, some scattered VCAM-1 immunoreactivity
was noted at the site of injury. Intravenous administration of
blocking antibodies directed to VCAM-1 (MK2.7 clone) or its
counterreceptor, Very Late Antigen-4 (VLA-4; a4b1) (PS2 clone),
to Cx3cr1GFP/+ chimeric mice immediately and 48 hr after SC
insult resulted in a reduction to 50% of monocyte-macrophages
at the lesion site (day 5 after injury) (Figure 4F). IgG isotype-
matched antibodies were used as controls. Reduction was veri-
fied in a nonchimeric system by monitoring CD45hiCD11bhi
expression (Figure S3). A reduction in GFP+ cells was also
found in the CP and CSF after VLA-4 antibody treatment (Fig-
ure S3) but not in the leptomeninges adjacent to the lesion (Fig-
ure S3). Notably, the significant reduction at the lesion site by
the blocking of the VCAM-1-VLA-4 interaction was restricted
to the Ly6cloCx3cr1-GFPhi and not the Ly6chiCx3cr1-GFPlo
monocyte-macrophage population (Figure 4G). Blocking anti-
bodies (clone M1/70) directed to CD11b, an integrin that is ex-
pressed by monocytes and can potentially interact with ICAM-1
in the CP, had no effect on either overall homing or that of
a specific monocyte-macrophage subset to the injured SC
(Figure 4H).
Because monocyte-macrophages promote recovery via IL-10
production (Shechter et al., 2009), we tested whether blockage
of CP-homing determinants would skew the cytokine milieu
within the lesion site. Injured mice received, as above, neutral-
izing antibodies to VCAM-1-VLA-4 interaction or APCP. Spinally
injured Cd73/ mice were also analyzed. Multiplex protein
analysis of the excised SC (day 7) revealed a selective reduction
of IL-10 and IL-13 in the treated groups, relative to the relevant
controls (Figure 5A). Under these experimental conditions,
the overall cytokine milieu was shifted toward a proinflamma-
tory one, as determined by qRT-PCR for several cytokines
(Figure 5B).epithelial flattening or attenuation, and asterisk indicates ventricular flocculent
31. Arrowheads mark areas with disorganized epithelial tight junctions. n = 3
for Ocln, encoding occludin. n = 3–4 per time point. ANOVA: F = 6, p = 0.03.
in F). n = 3–4 mice.
OVA: (i) F5,12 = 3.12, p = 0.04; (ii) F3,15 = 27.05, *p < 0.0001 relative to uninjured.
egative controls; pools of ten mice.
uninjured) and (K) Luminex (pools of six mice; results of day 0 are presented as
), 50 mm in (A)–(C), and 10 mm in (F). See also Figure S2.
Figure 4. CP CD73 and VCAM-1 Orchestrate the Trafficking of Monocytes Maturing into M2 at the Injured SC Site
(A and B) CD73 expression by CP epithelium (A) and not by blood CD115+ monocytes (B) of spinally injured mice.
(legend continued on next page)
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numbers of monocyte-macrophages (Shechter et al., 2009).
We therefore tested whether blocking these CP-homing deter-
minants would impair recovery. Mice were subjected to SCI,
randomly divided into groups, and treated as above. Motor func-
tion analyses of the hind limbs starting from day 1 postinjury,
a time point at which the average score of all groups was similar,
revealed from day 3 onward impairment of recovery by specific
VCAM-1-VLA-4 blocking antibodies relative to the controls (Fig-
ure 5C). In another set of experiments, which included injured
mice receiving APCP or PBS and a group of age-matched
Cd73/ mice (with similar group average scores at the starting
point [d1]), reduced recovery was similarly observed from day 4
onward in theCd73/mice and in the APCP-treated mice, rela-
tive to PBS-treated wild-type mice (Figure 5C). The timing of
motor score impairment correlated with the kinetics ofM2mono-
cyte-macrophage accumulation at the lesion site (Figure 1B). On
day 21 after the injury, the SCs were analyzed for lesion size by
Luxol fast blue and Nissl staining; treatments interrupting CD73
activity or the VCAM-1-VLA-4 interaction resulted in extended
lesion size, suggesting increased spread of damage (Figure 5D).
Thus, blocking the CP-guiding determinants VCAM-1-VLA-4
and CD73 resulted in reduced M2 recruitment, proinflammatory
milieu, and impaired functional recovery.
The CSF Provides an M2-Supportive Pathway for
Infiltrating Monocytes
Homing through the CP to the injured SC parenchyma requires,
beyond the migration across the CP, anterograde trafficking
through the CSF and/or the central canal, a CSF-filled space
that runs longitudinally through the SC and is continuous with
the ventricular spaces. Immunohistochemical analysis of injured
Cx3cr1GFP/+ chimeras revealed the presence of GFP+ mono-
cytes in the meninges connecting the CPs and upstream the
three apertures in the fourth ventricle, through which the ventric-
ular system communicates with the subarachnoid space
(foramen ofMagendie and Luschka) (Figure 6A). Such cells could
not be detected in uninjured mice. Flow cytometric analysis of
CSF samples aspirated from nonchimeric Cx3cr1GFP/+ mice
through the cisterna magna revealed the appearance of
numerous GFP+ cells (monocyte characteristics are shown in
Figure S4) 24 hr after injury (Figure 6B), reaching 50% of the
leukocytes in the CSF on day 3 (Figure 6C); GFP+ monocytes
were barely detectable in the CSF a few hours after trauma or
in uninjuredmice. Analysis of spinal cord sections ofCx3cr1GFP/+
chimeras revealed the presence of GFP+ cells also throughout
the central canal (Figure 6A). Such cells could not be detected(C) CD11b+CD115+CD45.1+ monocyte-macrophages in injured (d14) CD45.1/W
t test: n = 5–7 mice; SC, p = 0.007; blood, p = 0.31; percentages are of CD11b.
(D) Monocyte-macrophages (CD11b+CFSE+) at the lesion site (d7) of Cd73/ m
injected 24 hr before injury. Values are absolute cell numbers in 0.5 cm SC tissu
(E) VCAM-1 expression by CP endothelium after SCI (n = 3–4 mice).
(F and G) Monocyte-macrophages (GFP+Ly6c+CD11b+) in injured Cx3cr1GFP/+
matched antibodies, as controls. n = 5 mice per group. Student’s t test: (F) VLA-
p = 0.01; Ly6chiCx3cr1-GFPlo p = 0.35. (Gii) Two-way ANOVA: F1,23 = 17.24, p = 0.
cells.
(H) Monocyte-macrophages (GFP+Ly6c+CD11b+) in injured (d5) Cx3cr1GFP/+ chi
group. Two-way ANOVA: F1,30 = 1.23, p = 0.28.
Data are represented as mean ± SEM. Scale bars represent 50 mm in (Ai) and (E
562 Immunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc.in uninjured mice. In injured Cx3cr1GFP/+ chimeras, multiprocess
and ameboid GFP+ cells were associated with the apical and
luminal ependyma, respectively, of the central canal (marked
with Hoechst dye or the ependymal marker Vimentin) (Figures
6D and 6E), possibly reflecting active migration. Scanning elec-
tronmicroscopy of the opened central canal, clearly identified by
its cuboidal ependymal lining, revealed cells with typical leuko-
cyte morphology (Figure S4) that were not seen in uninjured
controls.
The injury-induced trafficking of leukocytes along the central
canal correlated with its morphological changes and activation.
The central canal was dilated by approximately 45% in close
proximity to the lesion site relative to uninjured (1,766 ± 118)
on days 1, 3, and 7 postinjury (2,562 ± 171; 2,294 ± 103; and
2,547 ± 141 mm2, respectively; n = 4 mice each; ANOVA, F =
9.3, p = 0.0018), possibly reflecting CSF flow disturbance within
the central canal (Radojicic et al., 2007). Adjacent to the lesion
site, the central canal exhibited increased vimentin (Figures 6F
and 6D) and GFAP immunoreactivity (not shown) and contained
in its lumen a vimentin-immunoreactive fiber structure (Fig-
ure 6D). Numerous GFP+ cells were colocalized with these fibers
(Figure 6D), possibly facilitating their migration. Moreover,
elevated expression of the integrin ligand ICAM-1 and the
chemokine Cxcl12 (SDF-1), in the first few days postinjury (day
0, 2, 3), was noted at the luminal surface of the central canal in
close proximity to the lesion site but not rostally (Figure 6F).
To establish that the monocytes that trafficked through the
CSF and central canal corresponded to the M2 monocyte-
macrophages found in the injured SC parenchyma, we injected
into the cisterna magna (the site of CSF flow after circulating in
the brain ventricles) a nontoxic polymerizing agent (Matrigel) to
mechanically block CSF flow (Slobodian et al., 2007). The
Matrigel deposit was restricted to the cisterna magna and the
fourth ventricle and did not spread to the lower compartments
(Figure S4). Such a treatment did not evoke signs of inflamma-
tion at the site of needle insertion, adjacent to the ventricles, or
at the SC and the leptomeninges (Figure S4). Matrigel injection
caused brain ventricular enlargement, with no detectable
anatomical changes in the SC parenchyma or meninges, below
the Matrigel injection site (Figure S4). Flow cytometric analysis
assessed 1 week after the SCI and Matrigel injection revealed
a significant reduction in GFP+ monocyte-macrophages (in
Cx3cr1GFP/+ chimeras) (Figure 6G) or in CD11bhiCD45hi-express-
ing cells (in nonchimeric mice) at the lesion site (Figure S4).
Subpopulation analysis revealed that the reduction was selec-
tive for only Ly6cloCx3cr1-GFPhi monocyte-macrophages at
the lesion site (Figure 6H), suggesting that the CP-CSF pathwayT (CD45.2) chimeras, after treatment with APCP, a CD73 inhibitor. Student’s
ice and their controls. Student’s t test: n = 4–5 mice, p = 0.01. CFSE was i.v.
e.
chimeras (d5), i.v. injected with VLA-4 (PS2) or VCAM-1(MK2.7) or isotype-
4 antibodies: p = 0.01; VCAM-1 antibodies: p = 0.03. (Gi) Ly6cloCx3cr1-GFPhi
0004. Values are absolute cell numbers in 0.5 cmSC tissue, per 20,000 CD11b+
mera SC, i.v. injected with CD11b (or isotype matched) antibodies. n = 6 per
) and 20 mm in (Aii). See also Figure S3.
Figure 5. The CP-Dependent Recruited Cells Resolve Inflammation and Improve Recovery
VLA-4-VCAM-1 interaction (by VLA-4 or VCAM-1 antibodies) or CD73 activity (using APCP, or Cd73/) was inhibited in SC-injured mice; appropriate controls
were included.
(legend continued on next page)
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Healing Macrophages Home to SCI via Choroid Plexusorchestrates the specific recruitment of M2 monocyte-macro-
phages to the lesion.
We next tested whether such an extended ‘‘detour’’ to the
lesion site through the CP and the CSF could potentially provide
an environment supportive of M2 commitment. Simultaneous
Multiplex analysis (by Luminex) revealed that whereas the lesion
site was predominated by proinflammatory cytokines, the CP
and the CSF continuously exhibited an anti-inflammatory bias
(Figure 7A). IL-13, an M2 inducer (Gordon and Taylor, 2005),
was the dominant cytokine in both the CP and the CSF. TGF-b
and IL-10 were abundant in the CSF and CP, respectively (Fig-
ure 7A). The CP maintained its anti-inflammatory profile after
SCI, unlike the lesion site, which displayed an elevation of proin-
flammatory cytokines (Figure 7B) and transient reduction in
TGF-b expression (Figure 7C). Of the TGF-b family, the CSF ex-
pressed only the TGF-b2 isoform, shown to mediate immune
deviation in immune-privileged organs (Streilein, 2003). Immuno-
labeling for TGF-b revealed its high expression in the CP vascu-
lature, but not in any other brain area (Figure 7D), and along the
central canal of the injured SC (Figure 7E). The CP also ex-
pressed Vip and Thbs1, previously shown to promote immune
deviation in immune-privileged sites (Figure 7F; Streilein, 2003).
Finally, based on the unique environment of the CSF, we
tested whether direct intracerebroventricular (ICV) injection of
naive CD115+ monocytes isolated from the BM (>80% Ly6chi)
would be sufficient to support functional recovery. Monocyte
administration (day 3) to the CSF of SC-injured mice resulted in
improved hind limb motor function recovery (Figure 7G) and
decreased lesion size (Figure 7H), thereby demonstrating that
the CSF compartment supports the differentiation of beneficial
monocyte-derived cells.
DISCUSSION
In this studywe have shown that monocyte recruitment to injured
SC parenchyma is coordinated through two sites. The brain
ventricular CP orchestrates trafficking of monocytes that locally
mature to healing anti-inflammatory (M2) monocyte-macro-
phages, and the adjacent SC leptomeninges support trafficking
of monocytes that mature to proinflammatory M1 monocyte-
macrophages.
Outside the CNS, monocytes homed to injured tissue by direct
extravasation from parenchymal-embedded vasculature. In the
CNS, such entry would necessitate breaching the BBB. Although
we cannot exclude escape of some cells, the present study
suggests that in the acute phase of the response after SCI, the
critical time for recovery, monocytes rarely home via paren-
chymal vessels. It seems that the mechanical insult itself does
not trigger BBB activation. Yet, in the chronic phase, the
prolonged parenchymal inflammation eventually ‘‘inflames’’ the(A) Cytokine Multiplex analysis of lesion site (d7). n = 4–8 pools of 3 mice. Two-w
(B) qRT-PCR analysis of lesion sites for genes encoding proinflammatory cytokin
(C) Hind limbmotor function, assessed according to the BMS. Left: Motor score as
group. Left: repeated ANOVA: Fbetween groups(2,40) = 60.8, p < 0.0001; right: ANO
Fbetween groups(2,37) = 36.7, p < 0.0001; right: ANOVA: F = 32, p < 0.0001.
(D) Quantification of lesion size (d21; an average of 3 depths) and representative
sections. n = 8–10 mice per group. ANOVA: (i) F = 35, p = 0.02; (ii) F = 10.2, p =
Data are represented as mean ± SEM. Scale bars represent 100 mm (D).
564 Immunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc.BBB, leading to immune invasion; integrins are induced
(Kalderon, 2005) and perivascular cuffing is observed (Takigawa
et al., 2010) at 2–4 weeks posttrauma.
The CP, a ventricular BCSFB compartment with a villous
structure, facilitates CNS immunosurveillance (Ransohoff et al.,
2003). Along this pathway, leukocytes extravasate across the
endothelium, interact with the tightly connected epithelial cells,
and enter the CSF. Though investigated primary in the context
of T lymphocytes (Mills et al., 2008; Reboldi et al., 2009), recent
studies demonstrate that CP myeloid cells exchange with blood
precursors (which are not monocytes) (Anandasabapathy et al.,
2011; Chinnery et al., 2010) and that monocyte invasion to the
CP occurs after head trauma (Szmydynger-Chodobska et al.,
2012). Here, we suggest that the CP supports trafficking of
‘‘healing’’ cells to remote traumatized CNS site by serving as
a selective and ‘‘phenotype-shaping gate’’ for monocytes en
route to the lesioned parenchyma. Such M2 monocyte-macro-
phages secreted anti-inflammatory cytokines needed for micro-
glial arrest, thereby limiting spread of damage as is essential for
recovery (Shechter et al., 2009). Tissue remodeling (Shechter
et al., 2011), axonal regeneration (Yin et al., 2006), and cell
renewal were also supported by monocyte-macrophages but
occurred at a later stage.
Similarly to wound healing outside the CNS (Arnold et al.,
2007; Nahrendorf et al., 2007), two waves of monocyte-macro-
phages, corresponding to M1 and M2, were identified here to
operate in the injured SC, but via distinct routes. The two gates
were activated on the same timescale, so the sequential waves
seen at the lesion sites could reflect the distinct pathway lengths
and migration rates.
It seems that the microenvironment within CNS lesion does
not allow local conversion to an M2 phenotype, in line with the
inability of activated resident microglia to attain a resolving
phenotype at this critical stage (Shechter et al., 2009). Similarly,
myelin debris at the SC lesion site, which can potentially trigger
M2 commitment (Boven et al., 2006), promotes an inflammatory
response by phagocytic macrophages (Sun et al., 2010). Our
results, however, do not argue against potential conversion (Ar-
nold et al., 2007) at the injured CNS site beyond this critical
reparative time window. This explains why recruitment through
the CP-CSF, which primes M2 commitment, is supportive for
repair.
Integrating our previous findings that CCR2-depleting anti-
bodies impair healing and amplify microglial inflammation
(Shechter et al., 2009) with the current observations suggests
that both M1 and M2 originate from a common circulating
CCR2+Ly6chi monocytic precursor, though only M1 is recruited
via its ligand CCL2. In EAE, interference with CCR2 guidance
also selectively impairs the recruitment of the Ly6chiCX3CR1lo
subset, leaving the reciprocal subpopulation unchangeday ANOVA: F5,74 = 11.1, p < 0.0001.
es, presented as a heat map relative to the relevant control.
a function of time. Right: Scores (d21) of individual mice. (i) n = 14–15 mice per
VA, F = 59, p < 0.0001. (ii) n = 12–15 mice per group. Left: repeated ANOVA:
pictures, as demarcated by Luxol and Nissl reactivity in longitudinal coronal
0.0007.
Figure 6. Homing of M2 Monocyte-Macrophages to the Injured Parenchyma through the Cerebrospinal Fluid
(A–C) Quantification of GFP+ cells inCx3cr1GFP/+ chimeras after SCI (A) in sections (30 mm) of brains and SC. # in segments of 0.5 cm; n = 4–8mice per time point.
ANOVA: F = 4.7, *p < 0.0001 relative to uninjured.
(legend continued on next page)
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which M1 outnumber M2, CCL2 has been viewed as the sole
‘‘ticket’’ to the CNS for monocytes (Mildner et al., 2009).
CP trafficking was found here to require a unique set of homing
determinants including the integrin VLA-4-VCAM-1 interaction
and the adenosine catalyzing enzyme CD73. Unlike CD73’s
role in preventing endothelial crossing, CD73-dependent CP
transmigration involves adenosine-mediated induction of the
chemokine fractalkine (Mills et al., 2012). Fractalkine is a known
chemoattractant of monocytes, specifically of the CX3CR1hi
subset (Nahrendorf et al., 2007), found here in the CP; both
fractalkine and CX3CR1hi cells were elevated in the CP of SC-
injured mice.
The CP was found here to be predominated by the CX3CR1hi
monocytic subset and was found to support M2 differentiation.
In addition, the entire CP-CSF pathway was found as an M2
milieu, possibly priming trafficking monocytes to their M2
commitment prior to their arrival at the lesion site. Such a process
might involve a selection or priming of monocytes at the CP gate
and further education thereafter. Because bypassing the CP by
injection of the primary CCR2+Ly6chi cells to the CSF still
benefited repair, our results argue in favor of an M2-educative
mechanism along the entire CP pathway. Additional studies in
mice reveal that intracerebroventricular (ICV)-injected CCR2+
human monocytes home to lesion sites and locally express
IL-10 (E. Yoles, S. Snider, M. Tolmasove, A. Ruben, O. Gore,
S. Har-Nof, O.M., M. Hadani, and M.S., unpublished data).
Human CSF has been shown in vitro to suppress effector T cell
function and to promote a ‘‘deviated’’ macrophage phenotype
(Wilbanks and Streilein, 1992). Importantly, although we suggest
that the CP route biases the commitment of the traffickingmono-
cytes, final M2maturation occurs at the lesion site via interaction
with the local extracellular matrix (Shechter et al., 2011).
The M2-educative property of the CP route seems to contra-
dict the suggested role of CP entry in EAE induction (Reboldi
et al., 2009). It is possible that in inflammation-induced patholo-
gies such as EAE, unlike in ‘‘sterile injurious’’ ones, either patho-
genic cells take advantage of CNS surveillance process or the
educative nature of this CP-CSF pathway is malfunctioning. In
support of the former conjecture, CCL20, which has been found
to facilitate CP entry of pathogenic Th17 cells (Reboldi et al.,
2009), is constitutively expressed, even in the absence of
disease, possibly reflecting its role in CNS immunosurveillance.
One possibility is surveillance by T regulatory (Treg) cells, known
to express CCR6, the chemokine receptor to CCL20 (Kleine-(B) GFP+ cell count in the CSF assessed by flow cytometry (results are presen
t test; * relative to uninjured.
(C) GFP+ cell count in the CSF presented as percentages of live cells, as determ
n = 4–6 pools (of 8–12 mice); Student’s t test; * relative to uninjured.
(D) GFP+ cells in association with vimentin-immunoreactive fiber structure at t
chimeras. n = 3 mice.
(E) SC sections immunostained for visualization of GFP+ cells in the central can
mice each.
(F) Central canal stained for vimentin together with ICAM-1 (i) or SDF-1(ii).
(G and H) Cx3cr1GFP/+ chimeras were subjected to SCI concurrently with intrac
macrophages. Student’s t test: (G) n = 5–7 mice, p = 0.02; (H) n = 6–8 mice;
representative of three. In (H), cells from both gates were plotted on the same histo
are indicated.
Data are represented as mean ± SEM. Scale bars represent 20 mm in (D) and 10
566 Immunity 38, 555–569, March 21, 2013 ª2013 Elsevier Inc.wietfeld et al., 2005). Moreover, CCR6-CCL20 interactions guide
monocyte recruitment into other epithelial tissues such as the
mucosa or skin (Le Borgne et al., 2006), so this chemokine might
also play a role in monocyte transmigration of the CP.
The anatomical separation between the lesion site and the CP
suggests this pathway as a potential general ‘‘route-phenotype
orchestrating’’ mechanism for any CNS trauma and leukocyte
type. In this regard, it is tempting to speculate that neutrophil
activity may be similarly directed. These cells, recently acknowl-
edged for their phenotypic diversity (termed N1-N2 in analogy to
M1-M2), were reported as being either detrimental or beneficial
to CNS recovery. In support, neutrophils are detected in the CSF
and CP posttrauma (Szmydynger-Chodobska et al., 2009).
All together, our results suggest that the port of CNS entry
determines the fate of the monocyte-macrophages maturing at
the site of mechanical injury to the spinal cord. Entry through
distinct gates of monocyte-macrophages that correspond to
the knownM1 and M2 waves at the lesion site might be a unique
mechanism of CNS healing, and possibly of other immune-
privileged sites, in which multiple entry routes exist. Such
a discovery suggests the possibility of differential immune
manipulation at the distinct ports as a therapeutic approach for
acute and chronic CNS noninflammatory as well as inflammatory
pathologies.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6J, CD45.1, Cx3cr1GFP/+ (Jung et al., 2000), and Cd73/ (Fieschi and
Sacchetti, 1967) mice were handled according to the regulations formulated
by the Institutional Animal Care and Use Committee (IACUC).
Bone Marrow Radiation Chimeras
BM chimeras were prepared while shielding the head as detailed in Supple-
mental Experimental Procedures.
Spinal Cord Injury and Assessment of Functional Recovery
The SCs of deeply anesthetized mice were exposed by laminectomy at T12,
and moderate contusive centralized injury (1.3 mm tip; 2 mm height;
2 mm/s) was inflicted (Infinite Horizon SC impactor; Precision Systems).
Recovery was evaluated by hind-limb locomotor performance, according to
the open-field BMS (Basso et al., 2006), as detailed in Supplemental Experi-
mental Procedures.
Pharmacological Inhibition of CD73
Micewere injected both intraperitoneally (0.5mg) and subcutaneously (0.5mg)
daily for a period of 7–14 days with a,b-methylene ADP (APCP; Sigma), a CD73
inhibitor (Synnestvedt et al., 2002).ted as cell count per 100 ml CSF). n = 4–6 pools (of 8–12 mice); Student’s
ined by flow cytometry. Dashed line represents blood monocyte percentages.
he edge of the central canal (delineated by Vimentin) of injured Cx3cr1GFP/+
al (delineated by Vimentin or Hoechst) of injured Cx3cr1GFP/+ chimeras. n = 3
isternal Matrigel injection, and at d7, their SC were analyzed for monocyte-
Ly6cloCx3cr1-GFPhi p = 0.02; Ly6chiCx3cr1-GFPlo p = 0.66; one experiment
gram. Absolute numbers of cells in 0.5 cm SC tissue, per 20,000 CD11b+ cells,
mm in (E) and (F). See also Figure S4.
Figure 7. The CP-CSF Pathway Exhibits an M2-Supportive Milieu
(A–C) Luminex analysis of pooled (6–12 mice) samples of SC, CP, and CSF.
(legend continued on next page)
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Rat antibodies directed to VLA-4 (PS/2; 50 mg per mouse), VCAM-1 (M/K 2.7;
200 mg per mouse), or CD11b (M1/70; 100 mg per mouse) were intravenously
injected, and Hamster CCL2 antibody (2H5; 100 mg per mouse) was intraper-
itoneally injected, as detailed in Supplemental Experimental Procedures.
Isotype-matched antibody served as a control, according to the manufac-
turer’s recommendations (Bio Express).
CSF Collection
CSF was collected by the cisterna magna puncture technique, as detailed
in Supplemental Experimental Procedures. Pooled samples (9–12 mice; 5 ml
each) of equivalent volumes were analyzed, and results were normalized
to 100 ml.
Intracerebroventricular Stereotactic Injections
Location of designated point: depth of 2.0 mm from brain surface, 0.4 mm
posterior to the bregma, and 1.0 mm lateral to the midline. Monocytes
(0.5 3 106 cells; isolated BM; >80% Ly6chi) were injected in PBS (3 ml; 1 ml
per min). PBS served as a control.
CSF Flow Obstruction
Growth factor reduced Matrigel (BD Bioscience; 20 ml) was intracisternally
injected. MRI check confirmed ventricle dilation. This procedure did not cause
an inflammatory response at the needle puncture site, surrounding the ventri-
cles, in the SC, or in the leptomeninges (Figure S4; Slobodian et al., 2007).
Adoptive Transfer of Monocytes
CD115+ monocytes were isolated from BM, as detailed in Supplemental
Experimental Procedures.
Statistical Analysis
Student’s t test was used to compare two groups, and one-way ANOVA to
compare several groups, followed by the Fisher LSD procedure (*p = 0.05).
For multiple analyses of several groups, two-way ANOVA was done, followed
by Bonferroni test. Repeated-measures ANOVA was used for BMS scoring,
and follow-up by contrast t test (*p = 0.05). Results are presented as mean ±
SEM; y axis error bars indicate SEM. Whenever pooled samples were used,
the statistical analysis was based on the number of replicate pools without
considering the animal number comprising the pools.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2013.02.012.
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